 | • レポートコード：MRC2102QY12248 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のレニン阻害剤市場について種類別（150mg /錠、300mg /錠）、用途別（45歳以下、45〜55歳、55〜65歳、65歳以上）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・レニン阻害剤市場の概要 ・世界の主要地域別レニン阻害剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のレニン阻害剤市場規模2015-2026：種類別（150mg /錠、300mg /錠） ・世界のレニン阻害剤市場規模2015-2026：用途別（45歳以下、45〜55歳、55〜65歳、65歳以上） ・レニン阻害剤の米国市場規模2015-2020 ・レニン阻害剤のヨーロッパ市場規模2015-2020 ・レニン阻害剤の中国市場規模2015-2020 ・レニン阻害剤の日本市場規模2015-2020 ・レニン阻害剤の東南アジア市場規模2015-2020 ・レニン阻害剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・レニン阻害剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・レニン阻害剤の市場動向・機会・課題 ・調査の結論 |
Renin inhibitors are one of four classes of compounds that affect the renin-angiotensin-aldosterone system. Renin inhibitors produce vasodilation by inhibiting the activity of renin, which is responsible for stimulating angiotensin II formation. Renin is a proteolytic enzyme that is released by the kidneys in response to sympathetic activation, hypotension, and decreased sodium delivery to the distal renal tubule. Aliskiren (INN) (trade names Tekturna, US; Rasilez, UK and elsewhere) is the first in a class of drugs called direct renin inhibitors. Its current licensed indication is essential (primary) hypertension.
USA is still the largest consumption region of Tekturna, occupied about 56% market share globally, with revenue 39.21 million USD in 2017. At the same time, Asia will see the considerable growth since Noden Pharma DAC had successfully entered into an agreement with Orphan Pacific (Japan) and Lee’s Pharmaceutical Holdings Limited (China).
Market Analysis and Insights: Global Renin-Inhibitors Market
The global Renin-Inhibitors market size is projected to reach US$ 126.7 million by 2026, from US$ 85 million in 2020, at a CAGR of 6.8% during 2021-2026.
Global Renin-Inhibitors Scope and Market Size
The global Renin-Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Renin-Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Renin-Inhibitors market is segmented into
150mg/Tablet
300mg/Tablet
Segment by Application, the Renin-Inhibitors market is segmented into
Age below 45
Age 45-55
Age 55-65
Age above 65
The Renin-Inhibitors market is analysed and market size information is provided by regions (countries). Segment by Application, the Renin-Inhibitors market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Renin-Inhibitors Market Share Analysis
Renin-Inhibitors market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Renin-Inhibitors business, the date to enter into the Renin-Inhibitors market, Renin-Inhibitors product introduction, recent developments, etc.
The major vendors covered:
Novartis
Noden Pharma
1 Renin-Inhibitors Market Overview
1.1 Renin-Inhibitors Product Scope
1.2 Renin-Inhibitors Segment by Type
1.2.1 Global Renin-Inhibitors Sales by Type (2020-2026)
1.2.2 150mg/Tablet
1.2.3 300mg/Tablet
1.3 Renin-Inhibitors Segment by Application
1.3.1 Global Renin-Inhibitors Sales Comparison by Application (2020-2026)
1.3.2 Age below 45
1.3.3 Age 45-55
1.3.4 Age 55-65
1.3.5 Age above 65
1.4 Renin-Inhibitors Market Estimates and Forecasts (2015-2026)
1.4.1 Global Renin-Inhibitors Sales Growth Rate (2015-2026)
1.4.2 Global Renin-Inhibitors Revenue and Growth Rate (2015-2026)
1.4.3 Global Renin-Inhibitors Price Trends (2015-2026)
2 Renin-Inhibitors Estimate and Forecast by Region
2.1 Global Renin-Inhibitors Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Renin-Inhibitors Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Renin-Inhibitors Sales Market Share by Region (2015-2020)
2.2.2 Global Renin-Inhibitors Revenue Market Share by Region (2015-2020)
2.3 Global Renin-Inhibitors Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Renin-Inhibitors Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Renin-Inhibitors Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Renin-Inhibitors Estimates and Projections (2015-2026)
2.4.2 Europe Renin-Inhibitors Estimates and Projections (2015-2026)
2.4.3 China Renin-Inhibitors Estimates and Projections (2015-2026)
2.4.4 Japan Renin-Inhibitors Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Renin-Inhibitors Estimates and Projections (2015-2026)
2.4.6 India Renin-Inhibitors Estimates and Projections (2015-2026)
3 Global Renin-Inhibitors Competition Landscape by Players
3.1 Global Top Renin-Inhibitors Players by Sales (2015-2020)
3.2 Global Top Renin-Inhibitors Players by Revenue (2015-2020)
3.3 Global Renin-Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renin-Inhibitors as of 2019)
3.4 Global Renin-Inhibitors Average Price by Company (2015-2020)
3.5 Manufacturers Renin-Inhibitors Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Renin-Inhibitors Players (Opinion Leaders)
4 Global Renin-Inhibitors Market Size by Type
4.1 Global Renin-Inhibitors Historic Market Review by Type (2015-2020)
4.1.1 Global Renin-Inhibitors Sales Market Share by Type (2015-2020)
4.1.2 Global Renin-Inhibitors Revenue Market Share by Type (2015-2020)
4.1.3 Global Renin-Inhibitors Price by Type (2015-2020)
4.2 Global Renin-Inhibitors Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Renin-Inhibitors Sales Forecast by Type (2021-2026)
4.2.2 Global Renin-Inhibitors Revenue Forecast by Type (2021-2026)
4.2.3 Global Renin-Inhibitors Price Forecast by Type (2021-2026)
5 Global Renin-Inhibitors Market Size by Application
5.1 Global Renin-Inhibitors Historic Market Review by Application (2015-2020)
5.1.1 Global Renin-Inhibitors Sales Market Share by Application (2015-2020)
5.1.2 Global Renin-Inhibitors Revenue Market Share by Application (2015-2020)
5.1.3 Global Renin-Inhibitors Price by Application (2015-2020)
5.2 Global Renin-Inhibitors Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Renin-Inhibitors Sales Forecast by Application (2021-2026)
5.2.2 Global Renin-Inhibitors Revenue Forecast by Application (2021-2026)
5.2.3 Global Renin-Inhibitors Price Forecast by Application (2021-2026)
6 United States Renin-Inhibitors Market Facts & Figures
6.1 United States Renin-Inhibitors Sales Market Share by Company (2015-2020)
6.2 United States Renin-Inhibitors Sales Market Share by Type (2015-2020)
6.3 United States Renin-Inhibitors Sales Market Share by Application (2015-2020)
7 Europe Renin-Inhibitors Market Facts & Figures
7.1 Europe Renin-Inhibitors Sales Market Share by Company (2015-2020)
7.2 Europe Renin-Inhibitors Sales Market Share by Type (2015-2020)
7.3 Europe Renin-Inhibitors Sales Market Share by Application (2015-2020)
8 China Renin-Inhibitors Market Facts & Figures
8.1 China Renin-Inhibitors Sales Market Share by Company (2015-2020)
8.2 China Renin-Inhibitors Sales Market Share by Type (2015-2020)
8.3 China Renin-Inhibitors Sales Market Share by Application (2015-2020)
9 Japan Renin-Inhibitors Market Facts & Figures
9.1 Japan Renin-Inhibitors Sales Market Share by Company (3015-3030)
9.2 Japan Renin-Inhibitors Sales Market Share by Type (2015-2020)
9.3 Japan Renin-Inhibitors Sales Market Share by Application (2015-2020)
10 Southeast Asia Renin-Inhibitors Market Facts & Figures
10.1 Southeast Asia Renin-Inhibitors Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Renin-Inhibitors Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Renin-Inhibitors Sales Market Share by Application (2015-2020)
11 India Renin-Inhibitors Market Facts & Figures
11.1 India Renin-Inhibitors Sales Market Share by Company (2015-2020)
11.2 India Renin-Inhibitors Sales Market Share by Type (2015-2020)
11.3 India Renin-Inhibitors Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Renin-Inhibitors Business
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Business Overview
12.1.3 Novartis Renin-Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis Renin-Inhibitors Products Offered
12.1.5 Novartis Recent Development
12.2 Noden Pharma
12.2.1 Noden Pharma Corporation Information
12.2.2 Noden Pharma Business Overview
12.2.3 Noden Pharma Renin-Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Noden Pharma Renin-Inhibitors Products Offered
12.2.5 Noden Pharma Recent Development
…
13 Renin-Inhibitors Manufacturing Cost Analysis
13.1 Renin-Inhibitors Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Renin-Inhibitors
13.4 Renin-Inhibitors Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Renin-Inhibitors Distributors List
14.3 Renin-Inhibitors Customers
15 Market Dynamics
15.1 Renin-Inhibitors Market Trends
15.2 Renin-Inhibitors Opportunities and Drivers
15.3 Renin-Inhibitors Market Challenges
15.4 Renin-Inhibitors Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Renin-Inhibitors Sales (K Tablet) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Renin-Inhibitors Sales (K Tablet) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Renin-Inhibitors Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Renin-Inhibitors Sales (K Tablet) by Region (2015-2020)
Table 5. Global Renin-Inhibitors Sales Market Share by Region (2015-2020)
Table 6. Global Renin-Inhibitors Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Renin-Inhibitors Revenue Share by Region (2015-2020)
Table 8. Global Renin-Inhibitors Sales (K Tablet) Forecast by Region (2021-2026)
Table 9. Global Renin-Inhibitors Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Renin-Inhibitors Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Renin-Inhibitors Revenue Share Forecast by Region (2021-2026)
Table 12. Global Renin-Inhibitors (K Tablet) of Key Companies (2015-2020)
Table 13. Global Renin-Inhibitors Sales Share by Company (2015-2020)
Table 14. Global Renin-Inhibitors Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Renin-Inhibitors Revenue Share by Company (2015-2020)
Table 16. Global Renin-Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renin-Inhibitors as of 2019)
Table 17. Global Renin-Inhibitors Average Price (USD/K Tablet) of Key Company (2015-2020)
Table 18. Manufacturers Renin-Inhibitors Manufacturing Sites and Area Served
Table 19. Manufacturers Renin-Inhibitors Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Renin-Inhibitors Players
Table 22. Global Renin-Inhibitors Sales (K Tablet) by Type (2015-2020)
Table 23. Global Renin-Inhibitors Sales Share by Type (2015-2020)
Table 24. Global Renin-Inhibitors Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Renin-Inhibitors Price (K Tablet) by Type (2015-2020)
Table 26. Global Renin-Inhibitors Sales Share by Type (2021-2026)
Table 27. Global Renin-Inhibitors Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Renin-Inhibitors Revenue Share by Type (2021-2026)
Table 29. Global Renin-Inhibitors Price (K Tablet) by Type (2021-2026)
Table 30. Global Renin-Inhibitors Sales (K Tablet) by Application (2015-2020)
Table 31. Global Renin-Inhibitors Sales Share by Application (2015-2020)
Table 32. Global Renin-Inhibitors Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Renin-Inhibitors Price (K Tablet) by Application (2015-2020)
Table 34. Global Renin-Inhibitors Sales (K Tablet) by Application (2021-2026)
Table 35. Global Renin-Inhibitors Sales Share by Application (2021-2026)
Table 36. Global Renin-Inhibitors Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Renin-Inhibitors Revenue Share by Application (2021-2026)
Table 38. Global Renin-Inhibitors Price (K Tablet) by Application (2021-2026)
Table 39. United States Renin-Inhibitors Sales (K Tablet) by Company (2015-2020)
Table 40. United States Renin-Inhibitors Sales Market Share by Company (2015-2020)
Table 41. United States Renin-Inhibitors Sales (K Tablet) by Type (2015-2020)
Table 42. United States Renin-Inhibitors Sales Market Share by Type (2015-2020)
Table 43. United States Renin-Inhibitors Sales (K Tablet) by Application (2015-2020)
Table 44. United States Renin-Inhibitors Sales Market Share by Application (2015-2020)
Table 45. Europe Renin-Inhibitors Sales (K Tablet) by Company (2015-2020)
Table 46. Europe Renin-Inhibitors Sales Market Share by Company (2015-2020)
Table 47. Europe Renin-Inhibitors Sales (K Tablet) by Type (2015-2020)
Table 48. Europe Renin-Inhibitors Sales Market Share by Type (2015-2020)
Table 49. Europe Renin-Inhibitors Sales (K Tablet) by Application (2015-2020)
Table 50. Europe Renin-Inhibitors Sales Market Share by Type (2015-2020)
Table 51. China Renin-Inhibitors Sales (K Tablet) by Company (2015-2020)
Table 52. China Renin-Inhibitors Sales Market Share by Company (2015-2020)
Table 53. China Renin-Inhibitors Sales (K Tablet) by Type (2015-2020)
Table 54. China Renin-Inhibitors Sales Market Share by Type (2015-2020)
Table 55. China Renin-Inhibitors Sales (K Tablet) by Application (2015-2020)
Table 56. China Renin-Inhibitors Sales Market Share by Application (2015-2020)
Table 57. Japan Renin-Inhibitors Sales (K Tablet) by Company (2015-2020)
Table 58. Japan Renin-Inhibitors Sales Market Share by Company (2015-2020)
Table 59. Japan Renin-Inhibitors Sales (K Tablet) by Type (2015-2020)
Table 60. Japan Renin-Inhibitors Sales Market Share by Type (2015-2020)
Table 61. Japan Renin-Inhibitors Sales (K Tablet) by Application (2015-2020)
Table 62. Japan Renin-Inhibitors Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Renin-Inhibitors Sales (K Tablet) by Company (2015-2020)
Table 64. Southeast Asia Renin-Inhibitors Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Renin-Inhibitors Sales (K Tablet) by Type (2015-2020)
Table 66. Southeast Asia Renin-Inhibitors Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Renin-Inhibitors Sales (K Tablet) by Type (2015-2020)
Table 68. Southeast Asia Renin-Inhibitors Sales Market Share by Application (2015-2020)
Table 69. India Renin-Inhibitors Sales (K Tablet) by Company (2015-2020)
Table 70. India Renin-Inhibitors Sales Market Share by Company (2015-2020)
Table 71. India Renin-Inhibitors Sales (K Tablet) by Type (2015-2020)
Table 72. India Renin-Inhibitors Sales Market Share by Type (2015-2020)
Table 73. India Renin-Inhibitors Sales (K Tablet) by Application (2015-2020)
Table 74. India Renin-Inhibitors Sales Market Share by Application (2015-2020)
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Renin-Inhibitors Sales (K Tablet), Revenue (Million USD), Price (USD/K Tablet) and Gross Margin (2015-2020)
Table 78. Novartis Renin-Inhibitors Product
Table 79. Novartis Recent Development
Table 80. Noden Pharma Corporation Information
Table 81. Noden Pharma Description and Business Overview
Table 82. Noden Pharma Renin-Inhibitors Sales (K Tablet), Revenue (Million USD), Price (USD/K Tablet) and Gross Margin (2015-2020)
Table 83. Noden Pharma Renin-Inhibitors Product
Table 84. Noden Pharma Recent Development
Table 85. Production Base and Market Concentration Rate of Raw Material
Table 86. Key Suppliers of Raw Materials
Table 87. Renin-Inhibitors Distributors List
Table 88. Renin-Inhibitors Customers List
Table 89. Renin-Inhibitors Market Key Trends
Table 90. Renin-Inhibitors Key Opportunities and Drivers
Table 91. Renin-Inhibitors Market Challenges
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Renin-Inhibitors Product Picture
Figure 2. Global Renin-Inhibitors Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Renin-Inhibitors Market Share by Application in 2020 & 2026
Figure 6. Age below 45 Examples
Figure 7. Age 45-55 Examples
Figure 8. Age 55-65 Examples
Figure 9. Age above 65 Examples
Figure 10. Global Renin-Inhibitors Sales (K Tablet) Growth Rate (2015-2026)
Figure 11. Global Renin-Inhibitors Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Renin-Inhibitors Price Trends Growth Rate (2015-2026) (USD/K Tablet)
Figure 13. Global Renin-Inhibitors Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Renin-Inhibitors Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Renin-Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Renin-Inhibitors Sales (K Tablet) Growth Rate (2015-2026)
Figure 17. Europe Renin-Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Renin-Inhibitors Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Renin-Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Renin-Inhibitors Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Renin-Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Renin-Inhibitors Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Renin-Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Renin-Inhibitors Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Renin-Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Renin-Inhibitors Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Renin-Inhibitors Players Market Share by Revenue in Renin-Inhibitors 2015 & 2019
Figure 28. Renin-Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Renin-Inhibitors Revenue Share by Type (2015-2020)
Figure 30. Global Renin-Inhibitors Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Renin-Inhibitors Revenue Share by Application (2015-2020)
Figure 32. Global Renin-Inhibitors Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Renin-Inhibitors Sales Market Share by Type in 2019
Figure 34. United States Renin-Inhibitors Sales Market Share by Type in 2019
Figure 35. Europe Renin-Inhibitors Sales Market Share by Company in 2019
Figure 36. Europe Renin-Inhibitors Sales Market Share by Type in 2019
Figure 37. Europe Renin-Inhibitors Sales Market Share by Application in 2019
Figure 38. China Renin-Inhibitors Sales Market Share by Company in 2019
Figure 39. China Renin-Inhibitors Sales Market Share by Type in 2019
Figure 40. China Renin-Inhibitors Sales Market Share by Application in 2019
Figure 41. Japan Renin-Inhibitors Sales Market Share by Company in 2019
Figure 42. Japan Renin-Inhibitors Sales Market Share by Type in 2019
Figure 43. Japan Renin-Inhibitors Sales Market Share by Application in 2019
Figure 44. Southeast Asia Renin-Inhibitors Sales Market Share by Company in 2019
Figure 45. Southeast Asia Renin-Inhibitors Sales Market Share by Type in 2019
Figure 46. Southeast Asia Renin-Inhibitors Sales Market Share by Application in 2019
Figure 47. India Renin-Inhibitors Sales Market Share by Company in 2019
Figure 48. India Renin-Inhibitors Sales Market Share by Type in 2019
Figure 49. India Renin-Inhibitors Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Renin-Inhibitors
Figure 52. Manufacturing Process Analysis of Renin-Inhibitors
Figure 53. Renin-Inhibitors Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
プロトンポンプ阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Proton Pump Inhibitors Market The global Proton Pump Inhibitors market size is projected to reach US$ 2750.5 million by 2026, from US$ 2404.3 million in 2020, at a CAGR of 2.3% during 2021-2026. Global Proton Pump Inhibitors Scope and Market Size The global Proto…- PD-1・PD-L1阻害剤の世界市場レポート2020 PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors being developed for the treatment of cancer. PD-1 and PD-L1 are both proteins present on the surface of cells. Immune checkpoint inhibitors such as these are emerging as a front-line treatment for several types of cancer. Nort…
- 移行阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Migration Inhibitors Market The global Migration Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Migration Inhibitors Scope and Market Size The global Migration Inhibitors…
- ヒストンデアセチラーゼ阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Histone Deacetylase Inhibitors Market The global Histone Deacetylase Inhibitors market size is projected to reach US$ 2043.7 million by 2026, from US$ 1028 million in 2020, at a CAGR of 12.1% during 2021-2026. Global Histone Deacetylase Inhibitors Scope and Marke…
- チロシンキナーゼJAK阻害剤の世界市場レポート2020 Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway. These inhibitors have therapeu…